Studies of the KATP Channel Opening Activity of the New Dihydropyridine Compound 9-(3-Cyanophenyl)-3,4,6,7,9,10-Hexahydro-1,8-(2H, 5H)-Acridinedione in Bladder Detrusor In Vitro

Abstract

No AccessJournal of UrologyUrological Survey: Abstracts: Voiding Function and Dysfunction, and Female Urology1 Jun 1998Studies of the KATP Channel Opening Activity of the New Dihydropyridine Compound 9-(3-Cyanophenyl)-3,4,6,7,9,10-Hexahydro-1,8-(2H, 5H)-Acridinedione in Bladder Detrusor In Vitro J.H. Li, G.D. Yasay, S.T. Kau, C.J. Ohnmacht, D.A. Trainor, A.D. Bonev, T.J. Heppner, and M.T. Nelson J.H. LiJ.H. Li More articles by this author , G.D. YasayG.D. Yasay More articles by this author , S.T. KauS.T. Kau More articles by this author , C.J. OhnmachtC.J. Ohnmacht More articles by this author , D.A. TrainorD.A. Trainor More articles by this author , A.D. BonevA.D. Bonev More articles by this author , T.J. HeppnerT.J. Heppner More articles by this author , and M.T. NelsonM.T. Nelson More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63369-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Studies of the KATP Channel Opening Activity of the New Dihydropyridine Compound 9-(3-Cyanophenyl)-3,4,6,7,9,10-Hexahydro-1,8-(2H, 5H)-Acridinedione in Bladder Detrusor In Vitro." The Journal of Urology, 159(6), p. 2264 References 1 : Darifenacin-a novel bladder selective muscarinic antagonist for the treatment of urge incontinence. J. Urol., part 21996; 155: 600A. abstract 1156. Google Scholar 2 : Efficacy and tolerability of tolterodine versus oxybutynin and placebo in patients with detrusor instability. J. Urol., part 21997; 157: 103. abstract 402. Google Scholar 3 : Initial clinical experience with the selective phosphodiesterase (PDE)-1 isoenzyme inhibitor vinpocetine in the treatment of urge-incontinence and low compliance bladder. J. Urol., part 21997; 157: 187. abstract 727. Google Scholar Departments of Pharmacology and Medicinal Chemistry, Zeneca Pharmaceuticals Group, Zeneca, Incorporated, Wilmington, Delaware, and University of Vermont, Colchester, Vermont© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 159Issue 6June 1998Page: 2264 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information J.H. Li More articles by this author G.D. Yasay More articles by this author S.T. Kau More articles by this author C.J. Ohnmacht More articles by this author D.A. Trainor More articles by this author A.D. Bonev More articles by this author T.J. Heppner More articles by this author M.T. Nelson More articles by this author Expand All Advertisement PDF DownloadLoading ...